MARC Record from marc_columbia

LEADER: 06478fam a2200541 a 4500
001 4053786
005 20221027025039.0
008 960329t19961996ne a b 101 0 eng c
010 $a 96017379
020 $a0792387007 (hardback : alk. paper)
035 $a(OCoLC)34584000
035 $a(OCoLC)ocm34584000
035 $9AMF2868HS
035 $a(NNC)4053786
035 $a4053786
040 $aDNLM/DLC$cDLC$dDLC$dOrLoB-B
050 00 $aRC848.C5$bF34 1995
060 10 $aWI 703 F191bde 1996
082 00 $a616.3/62079$220
111 2 $aFalk Symposium$n(86th :$d1995 :$cBasel, Switzerland)
245 10 $aBile acids and immunology :$bproceedings of the 86th Falk Symposium (part I of the Basel Liver Week), held in Basel, Switzerland, October 17-18, 1995 /$cedited by P.A. Berg and U. Leuschner.
260 $aDordrecht ;$aBoston :$bKluwer Academic Publishers,$c[1996], ©1996.
300 $axiii, 295 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aFalk symposium ;$vv. 86
504 $aIncludes bibliographical references and index.
505 00 $g1.$tRole of MHC molecules in defence mechanisms to intracellular pathogens /$rM. Plebanski --$g2.$tPathophysiological role of Th1 and Th2 cells /$rP. Parronchi, E. Maggi and S. Romagnani --$g3.$tActivation of immunologically ignorant autoreactive T cells by cryptic epitopes /$rC. J. Elson, R. N. Barker, J. T. Beech and S. J. Thompson --$g4.$tBile acid metabolism and function in healthy man: possible interactions with the immune system /$rA. F. Hofmann, E. Frick and U. Bolder --$g5.$tMethylprednisolone: is there a role for PBC treatment? /$rE. Roda, P. Fusaroli, A. Pezzoli, F. Azzaroli, C. Mazzeo, A. M. Gioacchini, C. Cerre and G. Mazzella --$g6.$tBiliary lipid secretion rates and bile acid composition in bile after liver transplantation /$rK. A. Einarsson, B. Angelin and B.-G. Ericzon --$g7.$tImmunohistochemistry of intra- and extrahepatic cholestasis /$rH. P. Dienes, P. Schimarcher and A. Lohse --
505 80 $g8.$tExpression of MHC molecules during intra- and extrahepatic cholestasis and their pathogenetic implications /$rV. J. Desmet --$g9.$tExpression of stress proteins and steroid receptors in patients with cholestatic liver diseases /$rA. D. Jorge and D. R. Ciocca --$g10.$tRole of cytokines and adhesion molecules in the pathogenesis of biliary liver diseases /$rK. Tanikawa, K. Noguchi and K. Sasatomi --$g11.$tTumour necrosis factor-[alpha] in cholestatic liver diseases /$rJ. Prieto --$g12.$tThe effect of ursodeoxycholic acid on MHC antigens in liver cells /$rL. Theilmann, C. Benz, U. Tox, W. Stremmel and A. Stiehl --$g13.$tEffect of ursodeoxycholic acid on immune regulatory cells /$rO. N. Le, M. F. Beaudet, I. Youssef and K. Paradis --$g14.$tEffects of cheno- and ursodeoxycholic acids on the effectors of cell-mediated immunity /$rY. Calmus, P. Podevin and R. Poupon --$g15.$tMHC expression in liver and the effect of bile acids /$rJ. Neuberger and R. Joplin --
505 80 $g16.$tEffects of ursodeoxycholic acid on immunoglobulin and cytokine production and antigen presentation /$rM. Yoshikawa, Y. Matsui, N. Umemoto, J. Yamao, H. Kawamoto, S. Ishizaka, H. Fukui, N. Hozumi and T. Tsujii --$g17.$tMitochondrial and nuclear autoantigens in primary biliary cirrhosis /$rM. F. Bassendine and D. E. J. Jones --$g18.$tMolecular mimicry and primary biliary cirrhosis /$rJ. Van de Water, R. Coppel, Tai-Tung Yip, T. W. Hutchens and M. E. Gershwin --$g19.$tAntineutrophil cytoplasmic antibodies in primary sclerosing cholangitis /$rW.-J. Mayet, T. Orth, A. Schwarting, I. Helmreich-Becker and K.-H. Meyer zum Buschenfelde --$g20.$tCytokine profiles in primary biliary cirrhosis and primary sclerosing cholangitis /$rR. Klein, M. Leuschner, U. Leuschner and P. A. Berg --$g21.$tImmunosuppression in biliary liver diseases: new concepts and strategies /$rM. M. Kaplan --$g22.$tConcepts of the therapeutic effect of ursodeoxycholate /$rS. Guldutuna, G. Zimmer and U. Leuschner --
505 80 $g23.$tBile acid therapy in primary biliary cirrhosis /$rJ. Heathcote --$g24.$tLessons for ursotherapy in primary biliary cirrhosis /$rR. Poupon and R. E. Poupon --$g25.$tUrsodeoxycholic acid for the treatment of primary sclerosing cholangitis /$rA. Stiehl --$g26.$tThe treatment of primary biliary cirrhosis with ursodeoxycholic acid and prednisolone /$rM. Leuschner, S. Bhatti, S. Guldutuna and U. Leuschner --$g27.$tThe influence of ursodeoxycholic acid on cyclosporin A therapy /$rF. Gutzler, A. Stiehl and W. Stremmel --$g28.$tUrsodeoxycholic acid (UDCA) and methotrexate as a promising regimen for patients with primary biliary cirrhosis remaining symptomatic under UDCA alone /$rF. Kinkel, Y. Zietschamann, M. Lohner and H.-P. Buscher --$g29.$tUrsodeoxycholic acid with and without interferon-[alpha] in the treatment of chronic hepatitis /$rM. Podda, A. Crosignani, A. Larghi, P. Invernizzi, V. Magnani and M. Zuin --
505 80 $g30.$tEffect of ursodeoxycholic acid in patients after orthotopic liver transplantation /$rB.-G. Ericzon, G. Soderdahl, Fu-Hua Wang and K. Einarsson --$g31.$tAnalysis of experimental data on the concept of interactions between bile salts and immunological effector reactions /$rJ. Reichen.
650 0 $aLiver$xCirrhosis$xPathophysiology$vCongresses.
650 0 $aLiver$xCirrhosis$xImmunological aspects$vCongresses.
650 0 $aBile acids$xTherapeutic use$vCongresses.
650 0 $aBile ducts$xDiseases$vCongresses.
650 12 $aBile Acids and Salts$ximmunology.$0https://id.nlm.nih.gov/mesh/D001647Q000276
650 22 $aLiver Diseases$xpathology.$0https://id.nlm.nih.gov/mesh/D008107Q000473
650 22 $aLiver Diseases$ximmunology.$0https://id.nlm.nih.gov/mesh/D008107Q000276
650 22 $aCholestasis, Intrahepatic$ximmunology.$0https://id.nlm.nih.gov/mesh/D002780Q000276
650 22 $aMajor Histocompatibility Complex$ximmunology.$0https://id.nlm.nih.gov/mesh/D008285Q000276
650 22 $aUrsodeoxycholic Acid$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D014580Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aBerg, P. A.$0http://id.loc.gov/authorities/names/n96801122
700 1 $aLeuschner, U.$0http://id.loc.gov/authorities/names/n95802908
711 2 $aBasel Liver Week$d(1995)
830 0 $aFalk symposium (Series) ;$v86.$0http://id.loc.gov/authorities/names/n98041545
852 00 $boff,hsl$hRC848.C5$iF34 1995